Drug · DIN 02242966
UNITRON PEG
50µG/0.5ML DELIVERABLE DOSE. SINGLE-DOSE VIAL.
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since February 1, 2012; first marketed March 27, 2001.
- Drug Identification Number (DIN)
- 02242966
- Company (DIN owner)
- Merck Canada IncKirkland, Quebec, Canada
- Schedule
- Prescription; Schedule D
- Dosage form
- Powder For Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Peginterferon alfa-2b L03AB10
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PEGINTERFERON ALFA-2B | 74 MCG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 10, 2003: NOC 3485Supplement to a New Drug Submission (SNDS) · Product name change from peg-intron
- October 20, 2000: NOC 1387New Drug Submission (NDS)
Other DINs named UNITRON PEG
- DIN 02242967 · Cancelled Post Market
- DIN 02242968 · Cancelled Post Market
- DIN 02242969 · Cancelled Post Market